DeNovo Ventures is a venture capital firm based in Saratoga, California and founded in 2000.
With $650 million under management, DeNovo has made more than 40 investments in medical devices and biotechnology across three funds. They invest in all stages of enterprise development and growth - from early stage to late stage. They work to advise entrepreneurs and management teams over the full life cycle of their portfolio company.
DeNovo Ventures has made investments in Avedro, TearScience, Benvenue Medical, Spinal Kinetics, EndoGastric Solutions, MyoScience, TRIA Beauty, Avedro, Astute Medical and WaveTec Vision.
They exited their investments in Avedro, MyoScience, Astute Medical, AxoGen, OncoMed Pharmaceuticals, TearScience, Spinal Kinetics, Spinal Modulation, WaveTec Vision and Renovis.
DeNovo Ventures has raised a total of $650 million across three funds. They announced their De Novo Ventures I on January 2000, with a raised total of $100 million. In January 2004, they announced their De Novo Ventures II with a raised total of $250 million. And in January 2006, the announced their De Novo Ventures III with a raised total of $300 million.
Timeline
People
Colleen Cody
Employee
Frederick Dotzler
Managing Director
Henry Mire
Employee
Joe Mandato
Managing Director
Richard M. Ferrari
Managing Director
